Loading…
Loading…
EQUITY / NASDAQ · XNMS
Predictive Oncology Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗11.37 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 11.37 USD · Volume 332,302
63 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 21,905,767 USD | — | — |
| Net income | -17,205,882 USD | -2,070,462 USD | — |
| Operating profit | -17,328,010 USD | -2,659,868 USD | — |
| Total assets | 100,375,956 USD | — | — |
| Total equity | 34,045,195 USD | -1,653,398 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 21,905,767 USD | — | — | 10,790,850 USD | 10,790,850 USD | 181,667 USD | — | — |
| Net incomeIncome statement | -17,205,882 USD | -24,914,825 USD | -7,708,943 USD | — | -233,095,203 USD | -77,651,843 USD | -82,165,178 USD | -2,070,462 USD |
| Operating profitIncome statement | -17,328,010 USD | -25,056,691 USD | — | — | -180,915,715 USD | -3,279,864 USD | -8,226,779 USD | -2,659,868 USD |
| Total assetsBalance sheet | 100,375,956 USD | — | — | 52,888,346 USD | 52,888,346 USD | 3,137,298 USD | — | — |
| Total equityBalance sheet | 34,045,195 USD | — | 40,270,761 USD | 47,716,955 USD | 47,716,955 USD | -77,427,922 USD | — | -1,653,398 USD |
| Total liabilitiesBalance sheet | 66,330,761 USD | — | — | 5,171,391 USD | 5,171,391 USD | 80,565,220 USD | — | — |
| Capital expendituresCash flow statement | — | 17,121,106 USD | — | — | 0 USD | — | 0 USD | — |
| Gross profitIncome statement | — | — | — | — | — | -4,738 USD | 44,915 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.